American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,450 | 93,442 | 87,784 | 71,864 | 70,343 |
| Marketable Securities | N/A | N/A | N/A | N/A | 4 |
| Receivables | 11,921 | 10,502 | 11,141 | 10,273 | 9,781 |
| Inventories | 12,131 | 13,225 | 10,684 | 12,591 | 10,373 |
| Other current assets | 4,396 | 5,009 | 5,977 | 3,619 | 4,049 |
| TOTAL | $136,898 | $122,177 | $115,587 | $98,347 | $94,550 |
| Non-Current Assets | |||||
| PPE Net | 32,956 | 32,707 | 32,195 | 29,986 | 23,281 |
| Investments And Advances | 197 | 138 | 114 | 208 | 204 |
| Intangibles | 35,672 | 35,375 | 35,255 | 35,340 | 35,167 |
| Other Non-Current Assets | 1,680 | 1,658 | 1,797 | 1,712 | 1,678 |
| TOTAL | $70,505 | $69,878 | $69,361 | $67,246 | $60,329 |
| Total Assets | $207,585 | $192,370 | $185,274 | $167,227 | $156,603 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,488 | 1,454 | 1,451 | 1,308 | 625 |
| Accounts payable and accrued liabilities | 7,637 | 5,579 | 7,422 | 4,870 | 5,022 |
| Other current liabilities | 3,089 | 4,058 | 3,870 | 3,439 | 8,438 |
| TOTAL | $22,557 | $20,086 | $23,335 | $19,953 | $23,350 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,154 | 1,174 | 1,172 | 1,052 | 1,376 |
| Other Non-Current Liabilities | 3 | 5 | 9 | 13 | 16 |
| TOTAL | $5,813 | $5,794 | $5,762 | $6,046 | $6,090 |
| Total Liabilities | $28,371 | $25,879 | $29,097 | $25,999 | $29,440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74 | 65 | 65 | 64 | 63 |
| Common Shares | 65 | 65 | 64 | 64 | 63 |
| Retained earnings | 74,945 | 65,273 | 58,827 | 48,038 | 40,357 |
| Other shareholders' equity | 7,120 | 5,886 | 4,977 | 2,779 | 2,069 |
| TOTAL | $179,214 | $166,490 | $156,177 | $141,228 | $127,163 |
| Total Liabilities And Equity | $207,585 | $192,370 | $185,274 | $167,227 | $156,603 |